For years, the gold standard of UK healthcare was the physical presence of the GP surgery. You queued at 8:00 AM, you sat in a waiting room, and you filled out a paper form that had been photocopied so many times the text was barely legible. That world hasn't disappeared, but it has been profoundly disrupted. Telehealth adoption in the UK has moved from a pandemic-era emergency measure to a standard operational expectation.
As someone who has spent the last eight years in the trenches of UK healthtech—from NHS portal rollouts to building patient journeys for private clinics—I’ve watched this shift happen in real-time. Patients no longer ask, "Can we do this remotely?" They ask, "Why do I need to come in for this?"
The Normalization of the Remote Consultation
When we talk about video consultation normal, we aren't just talking about a Zoom call with a clinician. We are talking about the removal of "friction points." Patients today have high standards. They expect asynchronous messaging, digitised medical records that follow them, and, crucially, the ability to book a slot that doesn't involve a game of telephone tag with a busy reception desk.
The expectation has shifted from "access" (just getting seen) to "experience" (how easy it was to get seen). If a platform requires a patient to re-enter their NHS number or current medication list every time they log in, that platform has already failed the modern patient. We have moved from a model of "compliance" to a model of "patient-centric convenience."
The Evolution of Patient Expectations: A Comparison
The following table illustrates the shift in the patient mindset over the last decade.
The Medical Cannabis Journey: A Case Study in Digitisation
Nowhere is this shift more evident than in the medical cannabis space. In 2026, the patient journey is almost entirely digital. However, it is vital to be clear: this is a highly regulated, specialist-led path. We are not talking about "miracle" cures or unregulated access. We are talking about a clinical, evidence-based pathway that aligns with NICE NG144 guidelines.
In the UK, medical cannabis is prescribed by Specialist Consultants, not GPs. Because this involves specific eligibility criteria, the digitised patient journey has become the gatekeeper of safe, effective care.
The Role of Intelligent Screening
The modern medical cannabis journey usually begins with a screening questionnaire. This is where many platforms succeed or fail. A high-quality digital screening tool does three things:
If the questionnaire is too long or repetitive, the patient abandons the journey. If it’s too vague, it leads to clinicians spending ten minutes explaining why the patient isn't eligible, which is a massive drain on resources for both parties.
Where Tech Still Fails the Patient
Despite the massive strides in remote care expectations, we aren't there yet. As a content lead, I constantly see platforms that fall into the trap of "tech for tech’s sake." Here are the friction points I see daily:
- The "Information Silo": Patients are tired of filling out a form on a telehealth site, only for the consultant to ask them the exact same questions again. If you have the data, use it. Sync the portal to the EMR (Electronic Medical Record) properly. Unclear Next Steps: A common mistake is the "dead-end" page. After a consultation, the patient should know exactly how their prescription is being sent to the pharmacy, when they will receive a tracking link, and how to book their follow-up. Ambiguity here leads to anxiety. Ignoring Clinical Governance: I see too many startups treat health tech like retail tech. Healthcare isn't e-commerce. If your platform isn't prioritising patient safety and clinical oversight in every UX decision, you aren't disrupting; you're just cutting corners.
The Future: Towards "Invisible Care"
The ultimate goal for telehealth adoption in the UK isn't just to make consultations digital; it’s to make the administrative side of healthcare "invisible."
Patients want to be able to access their medication, update their information, and contact their clinician with the same ease they use to bank or shop. However, this must remain grounded in the reality of clinical guidelines like NICE NG144. We must ensure that digital platforms support the human clinician, rather than trying to replace the nuance of the doctor-patient relationship with an algorithm.
In 2026, the winners in the telehealth space aren't the ones with the flashiest apps. They are the ones that have figured out how to make a complex, highly regulated clinical journey feel simple, safe, and transparent for the patient. We’ve moved past the "is this possible?" phase. Now, we are in the "how can we make this better?" phase. And for compare medical cannabis clinics uk the UK patient, that is a very good thing.
Summary: Lessons for Healthtech Leaders
If you are building or managing patient-facing digital health platforms, keep these three principles in mind:
- Audit your friction points: Look at your form completion rates. Where are people dropping off? It’s usually because you’re asking for info they’ve already given you. Respect clinical boundaries: Avoid jargon, but don't oversimplify the medical process. Patients are smart—they value transparency about the regulatory path, especially with treatments like cannabis-based medicinal products. Design for outcomes, not just signups: A successful patient journey isn't a quick registration; it's a long-term relationship. Build for retention, not just the "conversion" metrics that appease investors.